DiagMetrics, Inc.

Patented EBC diagnostic with LFA for TB (1B tests/year need); next-gen platform uses GaN biosensor expands the diagnostic platform for many use-cases

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location Madison, CT 06443, USA
  • Currency USD
  • Founded April 2020
  • Employees 9
  • Incorporation Type C-corp
  • Website diagmetrics.com

Company Summary

DiagMetrics is a Delaware C-corp pioneering exhaled breath condensate (EBC) diagnostics. Our first product is a low-cost lateral flow assay for tuberculosis, co-developed with MilliporeSigma and now in field testing in India and Africa. With a platform IP portfolio and next-gen GaN biosensor under development, our business model focuses on global health markets and remote patient monitoring, scaling through strategic partners and CMO alliances.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free